Pharmaceutical monitoring of toxoplasma treatment associated with cytomegalovirus pneumonia in heart transplant patients
Throughout the treatment process of one patient of toxoplasmosis and cytomegalovirus(CMV)pneumonia,clinical pharmacist participated in formulating clinical treatment protocol,cooperated with clinicians in adjusting medications and provided individualized medication monitoring and managed drug-related adverse reactions to ensure the safety of drug use for better clinical outcomes.Implementing individualized medication monitoring by clinical pharmacist helped to lower the occurrence of drug-related adverse events,improve symptoms and optimize outcomes.Meanwhile,it could promote rational clinical drug use and ensure the safety of patients.
heart transplantationtoxoplasma pneumoniapharmaceutical monitoringrational drug use
NETL
NSTL
万方数据
